World War II weapon antidote could treat Parkinson’s

News

Author: Simge Eva DoganPublished: 12 December 2018

Prep: Cook: Serves:

Researchers at Purdue University, US, are studying a World War II chemical weapon antidote that they believe could be used to treat Parkinson’s.

It is believed the antidote, called dimercaprol, may be able to remove acrolein – a toxin that poisons neurons and can lead to the development of Parkinson’s disease.

In addition to this, researchers believe dimercaprol can increase the survival rate of brain cells, improve mobility and reduce symptoms of pain.

Riyi Shi, professor of neuroscience and biomedical engineering at Purdue University, said: “Our studies show that by removing the toxin (acrolein) from the brain, we are not just reducing the symptoms of Parkinson’s disease but also significantly reversing the damage of Parkinson’s disease. This could actually provide a new treatment for Parkinson’s patients.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website

Research survey assesses impact of holidays on Parkinson’s symptoms

Last Month

Next Month

Go Back

Share this story

Comments

Agenda

December 2015

Highlights: Dublin Voices of Hope Choir & neuroscience conference

Overcoming obstacles: why Parkinson’s won’t stop me competing on Ninja Warrior

Parkinson’s patient hopes to win ‘American Ninja Warrior’

September 2015

Highlights: Golf fundraisers, 24Hrs to Ottawa & SuperWalk

Could treadmill training improve Parkinson’s symptoms?

Researchers at a German university have found that using a treadmill may improve gait in people with Parkinson’s. As part of the study – published in medical journal ‘Human Movement Science’ – 38 participants living with the condition completed 40 minutes of treadmill training twice a week for a period of eight weeks. Of that group, 18 varied the surface incline on the treadmill while the other 20 did not. While the results showed improved gait in both training groups, those that varied the incline saw significant improvement in stride length, stance and walking speed. The researchers, based at Friedrich-Alexander University Erlangen-Nürnberg, Germany said: “[Parkinson’s disease] patients demonstrated marked gait adaptations to the eight-week treadmill intervention, which were partially retained after three months follow-up”.

EPDA signs new charter on workplace rights

The European Parkinson’s Disease Association (EPDA) has signed the Dying to Work Charter – a pledge protecting the workplace rights of people with serious conditions. The charter – part of the Trade Union Congress’ wider Dying to Work campaign – has so far protected over half a million workers in the UK. The Dying to Work campaign group, chaired by MEP Rory Palmer, is calling on the European Union to amend its current legislation. The campaign is asking for serious conditions to be identified as a ‘protected characteristic’ – meaning employees would enjoy a protected period after diagnosis which would ensure the couldn’t be unfairly dismissed. Russell Patten, secretary general at the EPDA, said: “At the EPDA, we are committed to improving employment conditions, reducing stigma and ensuring accessibility to essential services for all people with Parkinson’s disease.” Image: Rory Palmer MEP (left) and Russell Patten, secretary general at the EPDA…

New wearable device could counteract gait

Scientists at the National University of Ireland Galway have created a wearable device that they believe will help people with Parkinson’s to walk more easily. The device, named cueStim, is worn around the waist and delivers fixed rhythmic sensory stimulation to the wearer. This will counteract ‘freezing of gait’ symptoms that are often experienced by people living with the condition. The scientists collaborated with professionals from UK medical board NHS Greater Glasgow and Clyde to test the device, and found that it significantly reduced the time taken for a person with Parkinson’s to complete walking tasks. Gearóid Ó Laighin, professor of electrical engineering at NUI Galway, said: “We are now seeking additional clinical partners to work with NUI Galway in carrying out a comprehensive long-term clinical evaluation of cueStim in enhancing the quality of life of people with Parkinson’s disease through a funded programme of research.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

World War II weapon antidote could treat Parkinson’s

News

Author: Simge Eva DoganPublished: 12 December 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Agenda

December 2015

Interviews

Overcoming obstacles: why Parkinson’s won’t stop me competing on Ninja Warrior

Agenda

September 2015

Could treadmill training improve Parkinson’s symptoms?

EPDA signs new charter on workplace rights

New wearable device could counteract gait

{title}

Subscribe

World War II weapon antidote could treat Parkinson’s

News

Author: Simge Eva DoganPublished: 12 December 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Agenda

December 2015

Interviews

Overcoming obstacles: why Parkinson’s won’t stop me competing on Ninja Warrior

Agenda

September 2015

Could treadmill training improve Parkinson’s symptoms?

EPDA signs new charter on workplace rights

New wearable device could counteract gait

{title}

Subscribe

Sign in